Key result
Shorter stays and home discharges linked to ~$3245 savings with no increase in 30-day readmissions.
Why the study?
It is controversial whether shortening hospital stay and increasing discharge to home after primary total knee arthroplasty is safe and cost-effective.
Does a shortened length of stay and increased rate of discharge to home increase readmission rates or affect cost-effectiveness in patients undergoing primary total knee arthroplasty?
Cohort (n=2,328)
Does a shortened length of stay and increased rate of discharge to home increase readmission rates or affect cost-effectiveness in patients undergoing primary total knee arthroplasty?
p-value: p=.38
Shortening hospital stay and increasing discharge to home after total knee arthroplasty is cost-effective and does not increase 30-day readmission rates.
Supports accelerated arthroplasty pathways; leaves open confirmation in prospective trials.
BACKGROUND: It is controversial whether shortening the average length of hospital stay and increasing discharge from a rehabilitation facility to home with either health care or outpatient physical therapy is safe and cost-effective. METHODS: We computed the average length of hospital stay; the rate of discharge to a rehabilitation facility, home with health care, or home with outpatient physical therapy; the all-cause readmission rate within 30 days of discharge per year; and cost savings for 2328 consecutive patients treated with a unilateral primary total knee replacement between 2009 and 2014. RESULTS: The average length of hospital stay per year shortened from 2.0 to 1.3 days (P < .0001); the rate of discharge per year to a rehabilitation facility decreased from 41% to 1% and increased from 9% to 53% to home with outpatient physical therapy (P < .0001); and the rate of readmission within 30 days per year did not change (P = .38). The cost savings averaged $3245 per patient. CONCLUSIONS: A shorter length of hospital stay and an increased rate of discharge to home was not associated with an increased rate of readmission within 30 days and was cost-effective. LEVEL OF EVIDENCE: Level IV, Therapeutic study.
No takes yet. Share an insight, caveat, or question.
Barad et al. (2015) conducted a cohort in unilateral primary total knee replacement (n=2,328). Shortened length of hospital stay and increased discharge to home was evaluated on all-cause readmission rate within 30 days of discharge (p=.38). A shorter length of hospital stay (from 2.0 to 1.3 days) and increased discharge to home was not associated with an increased 30-day readmission rate (P=0.38) and saved $3245 per patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: